Actively Recruiting
PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics
Led by Tomsk National Research Medical Center of the Russian Academy of Sciences · Updated on 2026-03-17
1000
Participants Needed
1
Research Sites
287 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to assess the incidence of potentially inappropriate medication (PIM) administration, polypharmacy, and potential drug-drug-interactions (PDDIs) in cardiovascular patients enrolled in the reimbursement program in the time of coronavirus disease (COVID-19) pandemic. Medical information system (MIS) "BARS" will be used for inclusion and retrieval of relevant data of cardiovascular patients enrolled in the reimbursement programs in the Tomsk Region. The incidence rates of PIM prescriptions will be assessed in patients aged 75 years and older. Potentially inappropriate medications will be defined according to 2015 Beers criteria. Polypharmacy will be defined as being administered five or more medications at the same time. PDDIs will be checked with Medscape Drug Interaction Checker and rated as 'Contraindicated', 'Serious', and 'Requiring Monitoring'. Combined analysis of retrospective and prospective occurrences of study parameters will be performed. PIM-BARS will evaluate the incidence rates and patterns of PIM prescriptions, polypharmacy, and PDDIs in elderly cardiovascular patients enrolled in the reimbursement program in the time of COVID-19 pandemic.
CONDITIONS
Official Title
PIM Incidence in Older Cardiovascular Patients During COVID-19 Pandemics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Established diagnosis of cardiovascular disease
- Age of 18 years and older
- Enrollment in the reimbursement program in Tomsk Region
You will not qualify if you...
- Age of 17 years and younger
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tomsk NRMC
Tomsk, Russia, 634012
Actively Recruiting
Research Team
N
Nina D Anfinogenova, PhD
CONTACT
N
Nadezhda I Ryumshina, MD, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here